Lupus Canada 2025 Catalyst Grant: Apply Now for Research Funding

by Ariana | Dec 5, 2024 | Article

Accelerate Lupus Research with the 2025 Catalyst Grant Lupus Canada is excited to announce the 2025 Catalyst Grant, designed to support innovative research ideas focusing on discoid or systemic lupus erythematosus (SLE). This grant offers Canadian investigators the...

Exploring Cognitive Fatigue and Brain Function in Lupus: New MRI Study Reveals Insights into Cognitive Impairment Mechanisms

by Ariana | Oct 31, 2024 | Article

A pilot study examining the relationship between cognitive dysfunction and cognitive fatigue in SLE using structural and functional MRIs of the brain and focusing on the underlying mechanisms Cognitive impairment is commonly experienced by people with lupus. Treatment...

Megakaryocyte: a new player in systemic lupus erythematosus

by Ariana | Jun 24, 2024 | Article

Dr. Boilard and his team have determined that an SLE-prone environment alters bioenergetic functions and gene expression in bone marrow megakaryocytes (MK). The data obtained from the Lupus Canada Catalyst grant project had significant impact on Dr. Boilard’s team to...

Using CyTOF to dissect the interplay between Type I interferon and autoantibody production in Systemic Lupus Erythematosus

by admin | Apr 19, 2024 | Article

Dr. Joan Wither Senior Scientist, Krembil Research Institute Professor of Medicine and Immunology, University of Toronto Director of STAT (Urgent Assessment) Rheumatology Clinic, Toronto Western Hospital Director of Early Autoimmune Rheumatic Disease Clinic, Toronto...

Now Enrolling People with Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) For A Research Study.

by admin | Apr 19, 2024 | Article

Now Enrolling People with Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) For A Research Study Study Title:Phase 2 ALXN1210-NEPH-202 Study (clinicaltrials.gov NCT04564339) Study Sponsor:Alexion, Astra Zeneca Rare Disease Purpose of Study:The purpose of...